Before endorsing such a statement, there are two issues to be discussed, namely, what is a BcR repertoire that can be considered normal for a CLL patient cohort, and what is the normal comparator B cell to be used for repertoire analysis? Here, BCR is linked to B-cell chronic lymphocytic leukemia.